Krystal Biotech Inc
KRYS
Market Cap$4.27B
Close$
$236.19
57.2% upside
Current Fair Value
57.2% upsideUndervalued by 57.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.27 Billion |
|---|---|
| Enterprise Value | $3.92 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $3.12 |
| Beta | 0.7 |
| Outstanding Shares | 28,910,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 29.1 |
|---|---|
| PEG | 19.9 |
| Price to Sales | 12.52 |
| Price to Book Ratio | 4.29 |
| Enterprise Value to Revenue | 10.91 |
| Enterprise Value to EBIT | 28.43 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data